166 related articles for article (PubMed ID: 8599886)
1. Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis.
Biglino A; Sinicco A; Forno B; Pollono AM; Sciandra M; Martini C; Pich P; Gioannini P
Clin Immunol Immunopathol; 1996 Jan; 78(1):61-9. PubMed ID: 8599886
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome.
Linde A; Andersson B; Svenson SB; Ahrne H; Carlsson M; Forsberg P; Hugo H; Karstorp A; Lenkei R; Lindwall A
J Infect Dis; 1992 Jun; 165(6):994-1000. PubMed ID: 1316417
[TBL] [Abstract][Full Text] [Related]
3. Cytokine network and acute primary HIV-1 infection.
Sinicco A; Biglino A; Sciandra M; Forno B; Pollono AM; Raiteri R; Gioannini P
AIDS; 1993 Sep; 7(9):1167-72. PubMed ID: 8216972
[TBL] [Abstract][Full Text] [Related]
4. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
5. Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.
Byrnes AA; Harris DM; Atabani SF; Sabundayo BP; Langan SJ; Margolick JB; Karp CL
J Leukoc Biol; 2008 Dec; 84(6):1447-53. PubMed ID: 18806124
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection.
Prince HE; Kleinman S; Czaplicki C; John J; Williams AE
J Acquir Immune Defic Syndr (1988); 1990; 3(5):525-30. PubMed ID: 1969960
[TBL] [Abstract][Full Text] [Related]
7. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens.
Bass HZ; Nishanian P; Hardy WD; Mitsuyasu RT; Esmail E; Cumberland W; Fahey JL
Clin Immunol Immunopathol; 1992 Jul; 64(1):63-70. PubMed ID: 1376654
[TBL] [Abstract][Full Text] [Related]
8. The IL-1 system in HIV infection: peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II.
Kreuzer KA; Dayer JM; Rockstroh JK; Sauerbruch T; Spengler U
Clin Exp Immunol; 1997 Jul; 109(1):54-8. PubMed ID: 9218824
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of interferon gamma, interleukin-6 and neopterin in patients with infectious mononucleosis and other Epstein-Barr virus-related lymphoproliferative diseases.
Schuster V; Herold M; Wachter H; Reibnegger G
Infection; 1993; 21(4):210-3. PubMed ID: 8225623
[TBL] [Abstract][Full Text] [Related]
10. Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.
Vinante F; Morosato L; Siviero F; Nadali G; Rigo A; Veneri D; de Sabata D; Vincenzi C; Chilosi M; Semenzato G
Haematologica; 1994; 79(5):413-9. PubMed ID: 7843627
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
12. Comparison of lymphocyte subpopulations in the peripheral blood of patients with infectious mononucleosis and human immunodeficiency virus infection: a preliminary report.
Zidovec S; Culig Z; Begovac J; Jeren T
J Clin Lab Immunol; 1998; 50(2):63-9. PubMed ID: 10470624
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
Marcante R; Cavedon G
Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
[TBL] [Abstract][Full Text] [Related]
14. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
[TBL] [Abstract][Full Text] [Related]
15. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women.
Mikyas Y; Aziz N; Harawa N; Gorre M; Neagos N; Nogueira M; Wafer D; Dillon M; Boyer PJ; Bryson YJ; Plaeger S
J Reprod Immunol; 1997 Jun; 33(2):157-70. PubMed ID: 9234214
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of serum intercellular adhesion molecule 1 in HIV infection are related to immune activation.
Diez-Ruiz A; Kaiser G; Jäger H; Birkmann J; Tilz GP; Wachter H; Fuchs D
Int Arch Allergy Immunol; 1993; 102(1):56-60. PubMed ID: 8104576
[TBL] [Abstract][Full Text] [Related]
17. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
18. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS.
Reddy MM; McKinley G; Englard A; Grieco MH
Int J Immunopharmacol; 1990; 12(7):737-41. PubMed ID: 2127261
[TBL] [Abstract][Full Text] [Related]
19. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha and soluble tumor necrosis factor receptors in individuals with human immunodeficiency virus infection.
Zangerle R; Gallati H; Sarcletti M; Wachter H; Fuchs D
Immunol Lett; 1994 Jul; 41(2-3):229-34. PubMed ID: 8002043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
